Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Lowering glucose concentrations may not be of any value in itself
| The first 150 words of the full text of this article appear below. |
EDITOR
Stratton et al have documented that as glycaemic exposure
increases, diabetic complications increase.1 They conclude that treatment of hyperglycemia will have substantial benefit, a
conclusion reiterated by Tuomilehto.2 Yet reduction of
glycaemic exposure did not have such benefit in the UK prospective
diabetes study (UKPDS) randomised trial.
3 4
The data by
Stratton et al suggest that reducing mean haemoglobin A1C
concentration by 1% would reduce diabetes related deaths by 21%.
Intensive treatment of hyperglycaemia for 10 years in UKPDS reduced
haemoglobin A1C by nearly 1% (from 7.9% to 7.0%) yet did
not reduce diabetes related deaths significantly.
The conventionally treated group, with greater glycaemic exposure,
experienced diabetes related death at a rate of 11.5 deaths per 1000 person years. On the basis of the data by Stratton et al, the
intensively treated group should have experienced diabetes related
death at a rate of 9.0 deaths per 1000 person years. Intensive treatment was, however, associated